Asia Pacific Biotech News (APBN) print edition appears once a month. Articles published in APBN are clear, concise and comprehensive. In accordance to the theme of the issue, editors serve to provide a good coverage of news and information in the School of Life Sciences; e.g. Pharmaceuticals, Healthcare, Policies & Regulatory Affairs, Acquisitions, Food & Agriculture, and Technology.
The web-content is updated on a regular basis, particularly, Twitter and Editors' Pick.
Sections of the magazine:
- Editor's Letter
- Eye on China
- Columns (contributions from Life Science editors)
- Inside Industry
- Conference Calendar
APBN serves to provide latest news and noteworthy information for professionals in the healthcare and pharmaceutical industries. The materials published in APBN (print and online) are interactive elements for investors, academics and researchers. This intellectual exchange is a clear, comprehensive and insightful platform for a broad-spectrum of audience located in Asia-Pacific, and international audience who are keen to know more about the biotechnology and healthcare industries in Asia-Pacific.
At APBN, the editors and contributing authors provide a good coverage of news published in Mandarin/ Chinese from China, Hong Kong, and Taiwan. News are verified and translated to English by in-house editors. One of our predominant goals is to broadcast news, articles, and events to companies located in Asia, Europe, India, and America.
Permission to Share
We are a firm believer in open-access of information, and with appropriate source or citation indicated at the end of each article. Information and media (e.g. videos, sound clips) would have had received appropriate permission for sharing and, publishing on the website and print.
For original content published by World Scientific & APBN editors or contributing authors, please seek for permission via email addressing to APBN editors: email@example.com